{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:52:57Z","timestamp":1770738777184,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.ygyno.2005.12.042","type":"journal-article","created":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T12:25:10Z","timestamp":1140611110000},"page":"270-277","source":"Crossref","is-referenced-by-count":26,"title":["Phase I\/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning"],"prefix":"10.1016","volume":"102","author":[{"given":"Martee L.","family":"Hensley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise D.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennapadam","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Sabbatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Spriggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2005.12.042_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl 3","key":"10.1016\/j.ygyno.2005.12.042_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bjc.6601494","article-title":"Primary ovarian cancer chemotherapy: current standards of care","volume":"89","author":"McGuire","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2005.12.042_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.12.042_bib4","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel vs. carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"Du Bois","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.12.042_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.1997.15.1.187","article-title":"Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer","volume":"15","author":"Fennelly","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/gyno.1996.0284","article-title":"Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel","volume":"63","author":"Shapiro","year":"1996","journal-title":"Gyncol. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib8","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.1998.16.10.3345","article-title":"Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy containing cisplatin or carboplatin and paclitaxel","volume":"16","author":"Bookman","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/gyno.2000.5921","article-title":"Phase 2 trial of liposomal doxorubicin (40 mg\/m2) in platinum\/paclitaxel refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum","volume":"78","author":"Markman","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1200\/JCO.1998.16.2.405","article-title":"Prolonged oral etoposide as second line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma. A Gynecologic Oncology Group study","volume":"16","author":"Rose","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2005.12.042_bib11","first-page":"82","article-title":"Preclinical in vivo evaluation of the combination of 2,3 difluorodeoxycytidine (dFdC, gemcitabine) and cisplatin (CDDP)","volume":"5","author":"Braakhuis","year":"1994","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib12","first-page":"357","article-title":"Gemcitabine, carboplatin and paclitaxel as first-line treatment of ovarian cancer FIGO Stages IIB\u2013IV","volume":"18","author":"Hansen","year":"1999","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G","article-title":"Cognitive deficits after postoperative adjuvant chemotherapy for breast cancer","volume":"85","author":"Schagen","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.12.042_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnci\/90.3.210","article-title":"Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard dose chemotherapy","volume":"90","author":"van Dam","year":"1998","journal-title":"J. Natl. Cancer Instit."},{"key":"10.1016\/j.ygyno.2005.12.042_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pon.2960040108","article-title":"Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer","volume":"4","author":"Wieneke","year":"1995","journal-title":"Psychooncology"},{"key":"10.1016\/j.ygyno.2005.12.042_bib16","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1200\/JCO.2000.18.14.2695","article-title":"Cognitive function in breast cancer patients receiving adjuvant chemotherapy","volume":"18","author":"Brezden","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-79-4-604","article-title":"Creatinine clearance: bedside estimate","volume":"79","author":"Jelliffe","year":"1973","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2005.12.042_bib18","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","article-title":"Carboplatin dosage: prospective evaluation of a simple formula based on renal function","volume":"7","author":"Calvert","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib19","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2001.19.6.1809","article-title":"Reliability and validity of the functional assessment of cancer therapy-ovarian","volume":"19","author":"Basen-Engquist","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/PMS.8.7.271-276","article-title":"Validity of the trail making test and an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept. Mot. Skills"},{"key":"10.1016\/j.ygyno.2005.12.042_bib21","series-title":"Wechsler adult intelligence scale\u2014Revised","author":"Wechsler","year":"1981"},{"key":"10.1016\/j.ygyno.2005.12.042_bib22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl. Psychol. Meas."},{"key":"10.1016\/j.ygyno.2005.12.042_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ygyno.2003.09.019","article-title":"Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study","volume":"92","author":"Look","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ygyno.2004.05.050","article-title":"Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer","volume":"94","author":"Micha","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2005.12.042_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sonc.2002.31593","article-title":"Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma","volume":"29","author":"Hansen","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib26","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1200\/JCO.2004.08.080","article-title":"Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study","volume":"22","author":"Bezjak","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib27","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/annonc\/mdf241","article-title":"Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients","volume":"13","author":"Schagen","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.20.2.485","article-title":"Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma","volume":"20","author":"Ahles","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib29","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1200\/JCO.2004.08.094","article-title":"Cognitive impairment associated with chemotherapy for cancer: report of a workshop","volume":"22","author":"Tannock","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S1041610291000728","article-title":"The high sensitivity cognitive screen","volume":"3","author":"Fogel","year":"1991","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.ygyno.2005.12.042_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00005053-196708000-00005","article-title":"Transfer of information from touch to vision in brain-injured and emotionally disturbed children","volume":"145","author":"Conners","year":"1967","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ygyno.2005.12.042_bib32","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.2003.01.119","article-title":"Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer","volume":"21","author":"Tchen","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.042_bib33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/13803390490510905","article-title":"Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen","volume":"26","author":"Castellon","year":"2004","journal-title":"J. Clin. Exp. Neuropsychol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805011157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805011157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T01:50:50Z","timestamp":1555465850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825805011157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0090825805011157"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.12.042","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}